v3.25.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Millions
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2025
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
Dec. 31, 2023
Cash flows from operating activities:          
Net earnings (loss) $ (387) $ (325) $ 54 $ 70 $ 41
Adjustments to reconcile net earnings (loss) to net cash from operating activities:          
Depreciation and amortization 53 158 157 207 230
Stock-based compensation   9 11 13 19
Impairment of goodwill and intangible assets 525 525   0 0
Deferred income tax expense (benefit)   (399) 6 10 22
Non-cash changes in taxes payable   206      
Other, net   (3) (4) (4) (4)
Change in operating assets and liabilities:          
Current and other assets   74 27 27 56
Payables and other liabilities   57 (28) (45) (88)
Net cash provided by (used in) operating activities   302 223 278 276
Cash flows from investing activities:          
Capital expenditures   (174) (183) (247) (222)
Grant proceeds received for capital expenditures   22 40 54 6
Other investing activities, net   6     2
Net cash provided by (used in) investing activities   (146) (143) (193) (214)
Cash flows from financing activities:          
Borrowings of debt   691 130 155  
Repayment of debt, tower obligations and finance leases   (778) (104) (107) (6)
Contributions from (distributions to) former member     (150)    
Other financing activities, net   (7)   (5) (5)
Net cash provided by (used in) financing activities   (94) (124) (107) (76)
Net increase (decrease) in cash, cash equivalents and restricted cash   62 (44) (22) (14)
Cash, cash equivalents and restricted cash, beginning of period   75 97 97 111
Cash, cash equivalents and restricted cash, end of period $ 137 $ 137 $ 53 $ 75 $ 97